Christopher Ung

Christopher Ung is the Chief Business Officer at CellCarta and an Advisory Board Member at STC Biologics. Christopher has held various executive positions in biotechnology companies such as HistoGeneX, Ligacept, Biomarker Laboratory, and Targeted Molecular Diagnostics. Christopher also has experience as the VP Strategic Business & Operations, Oncology at Quintiles Transnational and as the Chairman of the Pathology Business Group at Dako. Christopher holds an MBA in General Management from UCLA and an MSc in Chemistry from the University of California, Berkeley.